Login

A Financial Analyst at SilverStone Group, Inc. holding a Chemistry bachelor's degree and an MBA from Creighton University. 00:10:00

Share On Facebook Share On Twitter

Karan Keith Agarwal - Founder | CEO - Silverstone Group

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Ascendant Resources' Mark Brennan on Feasibility Study and Project Funding Challenges
00:10:00
Leveraging Mobility to Fuel Growth: Ken Piddington on Global Partners’ Digital Strategy | Ken Piddington - CIO, Global Partners LP
00:10:00
Navigating Political Risk: Junior Copper Ventures in the Philippines and Argentina
00:10:00
Geoffrey Benic, CEO of Aleafia Health Inc., and Louis Laflamme, CEO of Opsens Inc., share insights in "The View From The C-Suite."
00:10:00
Launching Mobile Backgammon Game with Real-Time Voice and Video Integration Aims to Boost User Engagement and Subscriptions | Jason Katz, CEO, Paltalk Inc.
00:10:00
Paul Heydon: Veteran Investor and Digital Media Expert, Leading the Charge in Game Sector Investments and Strategic Advising with $1B+ Transactions|Paul Heydon,Partner,London Venture Partners
00:10:00
Watch an exclusive interview with Salim Ghauri, Founder and CEO of NetSol Technologies, as he shares his success story and invaluable advice.
00:10:00
Dave Layton on Shaping a Successful Career in the Industry | Dave Layton, CEO, Partners Group.
00:10:00
Veon CEO Kaan Terzioğlu discusses the company's transformation into a more streamlined entity following its exit from Russia.
00:00:00
Edward M. Hundert, MD Former Dean for Medical Education
00:10:00
Investing in immigrant founders|Manan Mehta,Founding Partner,Unshackled Ventures
00:10:00
"Brian Rose Discusses Shifts in Growth Investing and Enterprise Software Markets"

© 2026 Nehu